Cover image of the article: Isatin-Based Anticonvulsant Agents Synthesis and Antiseizure Evaluation in Mice

Image Credit:J Rep Pharm Sci

Isatin-Based Anticonvulsant Agents Synthesis and Antiseizure Evaluation in Mice

Authors

Marzieh Rahmani Khajouei1, 2, 3, Ahmad Mohammadi-Farani1, 4, Daryoush Mirzaei3, 5, Alireza Aliabadi1, 3,*
1Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
2Isfahan Pharmaceutical Sciences Research Center, Isfahan, Iran
3Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
4Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciencesz, Kermanshah, Iran
5Department of Pharmacology, Toxicology and Medical Services, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran. Email:aliabadi.alireza@gmail.com

Journal of Reports in Pharmaceutical Sciences:Vol. 6, issue 1; 13-22
Published online:Jan 08, 2017
Article type:Research Article
Received:Oct 02, 2016
Accepted:Dec 25, 2016
How to Cite:Rahmani Khajouei M, Mohammadi-Farani A, Mirzaei D, Aliabadi A. Isatin-Based Anticonvulsant Agents Synthesis and Antiseizure Evaluation in Mice. J Rep Pharm Sci. 2017;6(1):e147618. doi:

Abstract

Based on the positive background of CNS activity of isatin analogs, a new series of isatin-based anticonvulsant derivatives (3a-3m) were designed and synthesized. According to the pharmacophoric necessities of anticonvulsant three essential parts namely aromatic ring (AR), electron donor (ED) group and hydrogen bond acceptor/donor (HAD) group were considered in the structure of designed compounds (3a-3m). Isatin was treated with various derivatives of aniline in the presences of glacial acetic acid under reflux condition. Two standard convulsive protocols namely maximal electroshock (MES) and pentylenetetrazole (PTZ) were utilized to investigate the anticonvulsant efficacy of these series. Besides, rotorod test was used to assess the neurotoxicity of corresponding compounds. Fortunately, the most of tested derivatives exhibited remarkable preventive effect in both applied convulsive models with low incidence of neurotoxicity in rotorod test.

Highlights

Copyright

© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Apr
2017
Docking, Synthesis and Anticonvulsant Activity of N-substituted Isoindoline-1,3-dione

Docking, Synthesis and Anticonvulsant Activity of N-substituted Isoindoline-1,3-dione

Maryam Iman,
Atefeh Saadabadi,
Asghar Davood,
Hamed Shafaroodi,
Ali Nikbakht,
Abdollah Ansari
,et al.

Iman M, Saadabadi A, Davood A, Shafaroodi H, Nikbakht A, et al. Docking, Synthesis and Anticonvulsant Activity of N-substituted Isoindoline-1,3-dione. Iran J Pharm Res. 2017;16(2):e125027. doi: https://doi.org/10.22037/ijpr.2017.2045

31
Aug
2015
Synthesis and Acetylcholinesterase Inhibitory Assessment of 3-(2-(4-benzoylpiperazin-1-yl) ethylimino) indolin-2-one Derivatives with Potential Anti-Alzheimer Effects

Synthesis and Acetylcholinesterase Inhibitory Assessment of 3-(2-(4-benzoylpiperazin-1-yl) ethylimino) indolin-2-one Derivatives with Potential Anti-Alzheimer Effects

Marzieh Rahmani Khajouei,
Ahmad Mohammadi-Farani,
Hamid Ghorbani,
Alireza Aliabadi

Rahmani Khajouei M, Mohammadi-Farani A, Ghorbani H, Aliabadi A. Synthesis and Acetylcholinesterase Inhibitory Assessment of 3-(2-(4-benzoylpiperazin-1-yl) ethylimino) indolin-2-one Derivatives with Potential Anti-Alzheimer Effects. J Rep Pharm Sci. 2015;4(2):e147677. doi:

31
Jul
2010
Synthesis of Two Novel 3-Amino-5-[4-chloro-2-phenoxyphenyl]-4H-1,2,4-triazoles with Anticonvulsant Activity

Synthesis of Two Novel 3-Amino-5-[4-chloro-2-phenoxyphenyl]-4H-1,2,4-triazoles with Anticonvulsant Activity

Mohammad Mahdavi,
Tahmineh Akbarzadeh,
Vahid Sheibani,
Maryam Abbasi,
Loghman Firoozpour,
Sayyed Abbas Tabatabai
,et al.

Mahdavi M, Akbarzadeh T, Sheibani V, Abbasi M, Firoozpour L, et al. Synthesis of Two Novel 3-Amino-5-[4-chloro-2-phenoxyphenyl]-4H-1,2,4-triazoles with Anticonvulsant Activity. Iran J Pharm Res. 2010;9(3):e126052. doi: https://doi.org/10.22037/ijpr.2010.865

31
Jul
2017
Anticonvulsant Effects of New 1, 4-DihydropyridineDerivatives Containing Imidazolyl Moiety Against Seizures Induced by Pentylenetetrazole and Maximal Electroshock in Mice

Anticonvulsant Effects of New 1, 4-DihydropyridineDerivatives Containing Imidazolyl Moiety Against Seizures Induced by Pentylenetetrazole and Maximal Electroshock in Mice

Yasaman Rasouli,
Asghar Davood,
Armin Alaee,
Golnoush Dehqani,
Hamed Shafaroudi,
Mahboubeh Lotfinia
,et al.

Rasouli Y, Davood A, Alaee A, Dehqani G, Shafaroudi H, et al. Anticonvulsant Effects of New 1, 4-DihydropyridineDerivatives Containing Imidazolyl Moiety Against Seizures Induced by Pentylenetetrazole and Maximal Electroshock in Mice. Iran J Pharm Res. 2017;16(3):e124986. doi: https://doi.org/10.22037/ijpr.2017.2099

2
Mar
2025
Design, Synthesis, Anticonvulsant Evaluation, and Molecular Docking Studies of New GABAA Agonist Derivatives

Design, Synthesis, Anticonvulsant Evaluation, and Molecular Docking Studies of New GABAA Agonist Derivatives

Mansur Nassiri Koopaei,
Parsa Moghimirad,
Ebrahim Saeedian Moghadam,
Nasrin Nassiri Koopaei,
Massoud Amanlou,
Tahmineh Akbarzadeh
,et al.

Nassiri Koopaei M, Moghimirad P, Saeedian Moghadam E, Nassiri Koopaei N, Amanlou M, et al. Design, Synthesis, Anticonvulsant Evaluation, and Molecular Docking Studies of New GABAA Agonist Derivatives. Iran J Pharm Res. 2025;24(1):e157392. doi: https://doi.org/10.5812/ijpr-157392

More by these authors

Marzieh Rahmani KhajoueiPubMedScholar
Ahmad Mohammadi-FaraniPubMedScholar
Daryoush MirzaeiPubMedScholar
Alireza AliabadiPubMedScholar
Share
Cited by
Metrics